NMIMC
NBIX icon

Northwestern Mutual Investment Management Company’s Neurocrine Biosciences NBIX Stock Holding History

Northwestern Mutual Investment Management Company’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.81M Buy
22,618
+135
+0.6% +$20K 0.04% 143
2026
Q1 		$2.96M Buy
22,483
+175
+0.8% +$23.2K 0.04% 168
2025
Q4 		$3.16M Buy
22,308
+201
+0.9% +$29.1K 0.04% 151
2025
Q3 		$3.1M Buy
22,107
+10
+0% +$1.35K 0.04% 159
2025
Q2 		$2.78M Sell
22,097
-72
-0.3% -$8.26K 0.04% 167
2025
Q1 		$2.45M Sell
22,169
-333
-1% -$42.2K 0.04% 180
2024
Q4 		$3.07M Buy
22,502
+99
+0.4% +$12.2K 0.07% 130
2024
Q3 		$2.58M Sell
22,403
-59
-0.3% -$8.09K 0.06% 170
2024
Q2 		$3.09M Buy
22,462
+267
+1% +$36.6K 0.08% 117
2024
Q1 		$3.06M Buy
22,195
+337
+2% +$46K 0.08% 123
2023
Q4 		$2.88M Buy
21,858
+200
+0.9% +$23K 0.08% 125
2023
Q3 		$2.44M Sell
21,658
-27
-0.1% -$2.84K 0.07% 127
2023
Q2 		$2.04M Buy
21,685
+256
+1% +$25K 0.05% 164
2023
Q1 		$2.17M Buy
21,429
+12,532
+141% +$1.3M 0.06% 137
2022
Q4 		$1.06M Sell
8,897
-4,915
-36% -$576K 0.03% 229
2022
Q3 		$1.47M Sell
13,812
-2,186
-14% -$222K 0.04% 182
2022
Q2 		$1.56M Buy
15,998
+242
+2% +$22.3K 0.04% 211
2022
Q1 		$1.48M Buy
15,756
+30
+0.2% +$2.54K 0.03% 287
2021
Q4 		$1.34M Buy
15,726
+91
+0.6% +$8.37K 0.03% 383
2021
Q3 		$1.5M Sell
15,635
-111
-0.7% -$10.5K 0.03% 297
2021
Q2 		$1.53M Buy
15,746
+136
+0.9% +$13K 0.03% 290
2021
Q1 		$1.52M Buy
+15,610
New +$1.64M 0.03% 280

Other funds holding NBIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Northwestern Mutual Investment Management Company's NBIX Position: Q2 2026 in Review

Northwestern Mutual Investment Management Company increased its Neurocrine Biosciences (NBIX) stake by 0.6% in Q2 2026, buying an estimated $20K and bringing the position to 22,618 shares worth $3.81M. The position accounts for 0.04% of the portfolio, ranked #143.

Northwestern Mutual Investment Management Company first reported a position in NBIX in Q1 2021 and has held it in 22 quarters since. 781 funds tracked by Wall St. Rank hold NBIX as of Q2 2026.

  • Northwestern Mutual Investment Management Company held 22,618 shares of Neurocrine Biosciences worth $3.81M as of Q2 2026.
  • Northwestern Mutual Investment Management Company bought 135 Neurocrine Biosciences shares in Q2 2026, an estimated $20K.
  • Neurocrine Biosciences made up 0.04% of Northwestern Mutual Investment Management Company's portfolio in Q2 2026, its #143 holding.
  • Northwestern Mutual Investment Management Company first reported a position in Neurocrine Biosciences in Q1 2021 and has held it in 22 quarters since.
  • 781 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q2 2026.

Based on Northwestern Mutual Investment Management Company's 13F filing for Q2 2026, filed 12 Aug 2026.